STAGG; John
Patent Applications and Registrations
Patent applications and USPTO patent grants for STAGG; John.The latest application filed is for "therapeutic combinations comprising eosinophil-depleting antibodies and uses thereof".
- STAGG; John - Montreal CA
| Patent | Date |
|---|---|
| Therapeutic Combinations Comprising Eosinophil-depleting Antibodies And Uses Thereof App 20200148758 - STAGG; John ; et al. | 2020-05-14 |
| Stromal antigen-presenting cells and use thereof Grant 7,553,661 - Galipeau , et al. June 30, 2 | 2009-06-30 |
| Stromal antigen-presenting cells and use thereof App 20060269526 - Galipeau; Jacques ; et al. | 2006-11-30 |
| Novel synthetic chimeric fusion transgene with immuno-therapeutic uses App 20050053579 - Galipeau, Jacques ; et al. | 2005-03-10 |
| Cultured stromal cells and uses thereof App 20050053587 - Galipeau, Jacques ; et al. | 2005-03-10 |
| NCAGE Code | 1VTS2 | STAGG JOHN |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 